IDH1 and neoplasm: This also contrasts isocitrate dehydrogenase (IDH)-mediated tumorigenesis, where IDH mutations are associated with genetic alterations that change over the course of the disease either through partnership with a different mutated gene or through acquisition of additional/different mutations in the same gene during tumour evolution17.